2nd Jul 2020 06:54
Oncimmune Holdings PLC - Nottingham, England-based cancer detection company - Says its distributor in Brazil, Valentech International LLC, has obtained marketing authorisation for the EarlyCDT Lung blood test. EarlyCDT Lung is used for the early detection of lung cancer, with the marketing authorisation obtained from Agencia Nacional de Vigilancia Sanitaria. The marketing authorisation is effective immediately. Oncimmune signed a distribution agreement with Valentech for Brazil and Colombia in 2018.
Current stock price: 133.95 pence
Year-to-date change: almost tripled
By Evelina Grecenko; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Oncimmune